Skip Ribbon Commands
Skip to main content
Skip to main navigation Skip to main content
Sign In

Ongoing cases

  • AUTH/3047/6/18 - Health professional v A Menarini
    Description:Promotion of Migard
    Case Status:Breach ruled, case report pending
    Last Updated:02/10/2018
  • AUTH/3034/4/18 - Health professional v AstraZeneca
    Description:Patient engagement webpages
    Case Status:Both the complainant and respondent can appeal
    Last Updated:02/10/2018
  • AUTH/3028/3/18 - Ex-Employee v AbbVie
    Description:Production of a poster and use of case studies
    Case Status:Breach ruled, appeal by complainant
    Last Updated:02/10/2018
  • AUTH/3027/3/18 - Voluntary admission by Sunovion
    Description:Working with Patient Organisations
    Case Status:Breach ruled, case report pending
    Last Updated:03/07/2018
  • AUTH/3025/3/18 - Member of the public v Merck Sharp & Dohme
    Description:Promotion of Nexplanon
    Case Status:No breach, outwith the scope of the Code
    Last Updated:28/06/2018
  • AUTH/3021/2/18 - Anonymous v Shire
    Description:Meeting advertised on LinkedIn
    Case Status:No breach, outwith the scope of the Code
    Last Updated:28/06/2018
  • AUTH/3020/2/18 - Anonymous v Lilly
    Description:Meeting advertised on LinkedIn
    Case Status:No breach, outwith the scope of the Code
    Last Updated:28/06/2018
  • AUTH/3019/2/18 - Anonymous v Boehringer Ingelheim
    Description:Meeting advertised on LinkedIn
    Case Status:No breach, outwith the scope of the Code
    Last Updated:28/06/2018
  • AUTH/3016/1/18 - Consultant Haematologist v Takeda
    Description:Alleged religious discrimination
    Case Status:No breach, outwith the scope of the Code
    Last Updated:02/10/2018
  • AUTH/3007/12/17 - Director v Vifor Fresenius
    Description:Clinical trial disclosure (Velphoro)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3006/12/17 - Director v Lilly
    Description:Clinical trial disclosure (Trulicity)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3004/12/17 - Director v Gilead
    Description:Clinical trial disclosure (Sovaldi)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3003/12/17 - Director v Clinuvel UK
    Description:Clinical trial disclosure (Scenesse)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3002/12/17 - Director v Octapharma
    Description:Clinical trial disclosure (Nuwiq)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3001/12/17 - Director v Sunovion
    Description:Clinical trial disclosure (Latuda)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/3000/12/17 - Director v Roche
    Description:Clinical trial disclosure (Gazyvaro)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/2999/12/17 - Director v Otsuka
    Description:Clinical trial disclosure (Deltyba)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/2998/12/17 - Director v Lilly
    Description:Clinical trial disclosure (Cyramza)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:13/04/2018
  • AUTH/2984/10/17 - Health Professional v Astellas UK
    Description:Promotion of Advagraf
    Case Status:Breach ruled, case report pending
    Last Updated:13/06/2018
  • AUTH/2967/8/17 - Consultant v Shire
    Description:Omission of prescribing information and other obligatory information
    Case Status:No breach, outwith the scope of the Code
    Last Updated:11/12/2017
  • AUTH/2966/8/17 - Consultant v Takeda
    Description:Promotion of vedolizumab
    Case Status:No breach, outwith the scope of the Code
    Last Updated:11/12/2017
  • AUTH/2909/11/16 - Director v Astellas UK
    Description:Clinical trial disclosure (Xtandi)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2907/11/16 - Director v Takeda
    Description:Clinical trial disclosure (Vipidia)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2905/11/16 - Director v A Menarini
    Description:Clinical trial disclosure (Spedra)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2904/11/16 - Director v Lundbeck
    Description:Clinical trial disclosure (Selincro)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2900/11/16 and AUTH/2910/11/16 - Director v Sanofi
    Description:Clinical trial disclosure (Lyxumia) and (Zaltrap)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2899/11/16 - Director v Aegerion
    Description:Clinical trial disclosure (Lojuxta)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2896/11/16 - Director v Janssen
    Description:Clinical trial disclosure (Invokana)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2895/11/16 - Director v Boehringer Ingelheim
    Description:Clinical trial disclosure (Giotrif)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2894/11/16 - Director v Mitsubishi Tanabe
    Description:Clinical trial disclosure (BindRen)
    Case Status:No breach, outwith the scope of the Code
    Last Updated:21/03/2017
  • AUTH/2891/11/16 - Ex-employee v Astellas
    Description:Certification and review of materials
    Case Status:No breach, outwith the scope of the Code
    Last Updated:24/01/2017
  • AUTH/2881/10/16 - Anonymous, non-contactable v Shire
    Description:Alleged Shire video on a public website
    Case Status:No breach, outwith the scope of the Code
    Last Updated:22/11/2016
  • AUTH/2858/7/16 - Health Professional v Bayer
    Description:Alleged promotion to the public
    Case Status:No breach, outwith the scope of the Code
    Last Updated:12/10/2016